There, Richard Peto, an Oxford University statistician, quieted the cancer scare before it really began.

FORBES: Magazine Article

"If you do enough significance tests, you're going to see some things that are statistically significant, " said Richard Peto, a statistician at Oxford University.

FORBES: Another Blow For Merck And Schering

The study, published online March 18 in the journal The Lancet, was conducted in part by the eminent epidemiologist Sir Richard Peto of the University of Oxford.

CNN: Obesity can shorten lifespan up to a decade

But Oxford University's Richard Peto, one of the world's top statisticians, presented an analysis of two ongoing Vytorin studies that he said showed the apparent cancer risk was a fluke.

FORBES: The Vytorin Saga

Sir Richard Peto, the renowned British statistician who conducted an analysis showing "no credible evidence" that the cholesterol medicine Vytorin causes cancer, defended himself in a sharply worded letter to congressmen investigating the medicine.

FORBES: Magazine Article

But, at the same time, they presented an analysis by Oxford University's Sir Richard Peto, who argued there is "no credible evidence" of a link between the active ingredient in Vytorin and Zetia and cancer.

FORBES: Magazine Article